欧盟EMA药品数据库-欧盟集中审批药品
(European Medicines Agency Authorisation of Medicines DataBase)
商品名称 适用类别 通用名称 活性成分 产品号 上市许可开发者/申请人/持有人 上市许可日期 许可状态
Oyavas Human bevacizumab bevacizumab EMEA/H/C/005556 STADA Arzneimittel AG 2021/03/26 Authorised
Seffalair Spiromax Human salmeterol;fluticasone propionate fluticasone propionate;salmeterol xinafoate EMEA/H/C/004881 Teva B.V. 2021/03/26 Authorised
Ontozry Human cenobamate cenobamate EMEA/H/C/005377 Angelini Pharma S.p.A 2021/03/26 Authorised
Byfavo Human remimazolam remimazolam besilate EMEA/H/C/005246 Paion Pharma GmbH 2021/03/26 Authorised
BroPair Spiromax Human salmeterol;fluticasone propionate salmeterol xinafoate;fluticasone propionate EMEA/H/C/005591 Teva B.V. 2021/03/26 Withdrawn
Thiotepa Riemser Human thiotepa thiotepa EMEA/H/C/005434 Esteve Pharmaceuticals GmbH 2021/03/26 Authorised
Pemazyre Human pemigatinib pemigatinib EMEA/H/C/005266 Incyte Biosciences Distribution B.V. 2021/03/26 Authorised
Nexpovio Human selinexor selinexor EMEA/H/C/005127 Stemline Therapeutics B.V. 2021/03/26 Authorised
Jcovden (previously COVID-19 Vaccine Janssen) Human COVID-19 vaccine (Ad26.COV2-S [recombinant]) adenovirus type 26 encoding the SARS-CoV-2 spike glycoprotein (Ad26.COV2-S) EMEA/H/C/005737 Janssen-Cilag International NV 2021/03/11 Withdrawn
Heplisav B Human hepatitis B surface antigen hepatitis B surface antigen EMEA/H/C/005063 Dynavax GmbH 2021/02/18 Authorised
Retsevmo Human selpercatinib selpercatinib EMEA/H/C/005375 Eli Lilly Nederland B.V. 2021/02/11 Authorised
Yuflyma Human adalimumab adalimumab EMEA/H/C/005188 Celltrion Healthcare Hungary Kft. 2021/02/11 Authorised
Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) Human lenalidomide lenalidomide hydrochloride monohydrate EMEA/H/C/005348 Krka, d.d., Novo mesto  2021/02/11 Authorised
Sunitinib Accord Human sunitinib sunitinib EMEA/H/C/005419 Accord Healthcare S.L.U. 2021/02/11 Authorised
Tukysa Human tucatinib tucatinib EMEA/H/C/005263 Pfizer Europe MA EEIG  2021/02/11 Authorised
Ogluo Human glucagon Glucagon EMEA/H/C/005391 Strongbridge Dublin Limited 2021/02/11 Authorised
Lenalidomide Krka d.d. Human lenalidomide lenalidomide hydrochloride hydrate EMEA/H/C/005729 Krka, d.d., Novo mesto  2021/02/11 Withdrawn
Lenalidomide Krka d.d. Novo mesto (previously Lenalidomide Krka) Human lenalidomide lenalidomide hydrochloride monohydrate EMEA/H/C/005734 Krka, d.d., Novo mesto  2021/02/11 Authorised
Inrebic Human fedratinib fedratinib dihydrochloride monohydrate EMEA/H/C/005026 Bristol Myers Squibb Pharma EEIG 2021/02/08 Authorised
Lumoxiti Human moxetumomab pasudotox moxetumomab pasudotox EMEA/H/C/005322 AstraZeneca AB 2021/02/08 Withdrawn

数据库说明:

©2006-2026 DrugFuture->European Medicines Agency Authorisation of Medicines DataBase